Natco Pharma Ltd

  • BSE Code : 524816
  • NSE Symbol : NATCOPHARM
  • ISIN : INE987B01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,027.55 25.65(2.56%)

Open Price ()

984.00

Prev. Close ()

1,001.90

Volume (No’s)

1,054,328

Market Cap ()

18,404.43

Low Price ()

978.45

High Price ()

1,031.00

 

Corporate Announcement

25-Mar-2026 Natco Pharma Limited - Shareholders meeting
24-Mar-2026 Natco Pharma Limited - Outcome of Board Meeting
20-Mar-2026 Natco Pharma Limited - Press Release
06-Mar-2026 Natco Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
24-Feb-2026 Natco Pharma Limited - News Verification

Stock Summary

Market Cap(₹Cr.)

18,409.81

P/E (TTM)

12.27

Book value ()

461.80

Div Yield (%)

0.58

EPS (TTM)

83.75

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

1,016.28

Resistance 2

1,030.67

Support 1

986.13

Support 2

970.37

Moving Average

30 Days

962.31

50 Days

911.16

100 Days

897.49

200 Days

892.78

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Natco Pharma Ltd 18,409.81 12.27 1.95 2465.6 0.58 83.75
Sun Pharmaceutical Indust.. 406,603.30 93.16 17.11 7162.05 0.94 18.19
Divis Laboratories Ltd 155,484.95 60.44 10.27 3332 0.51 96.91
Torrent Pharmaceuticals L.. 135,009.27 60.45 14.42 3583.06 0.15 65.99
Lupin Ltd 104,090.54 18.82 3.81 5569.31 0.53 120.95

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 30204868 16.86
Total Institutions 9654234 5.39
Total Govt Holding 1176 0.00
Total Non Promoter Corporate Holding 2531863 1.41
Total Promoters 88630126 49.48
Total Public & others 48087603 26.85
Total 179109870 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company as 'Natco Fine Pharmaceuticals Private Limited'. The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation dated 30 December 1994 issued by the RoC, Andhra Pradesh.

Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW). Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides.

In 1988, the company inaugurated a Parenterals manufacturing facility at Nagarajuna Sagar, Telangana. In 1993, the company inaugurated its chemical division at Mekaguda, Telangana. On 1 April 1995...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew